COVID-19 RCTs of Antivirals
Intervention
Outcome
Mortality
(n/N)
%
[CI]
Baseline
Diabetes Mellitus
(n/N)
%
[CI]
Baseline
Male Patients
(n/N)
%
[CI]
Interventions
1927/12189
10.5%
[8.8%, 12.5%]
3148/11217
27.8%
[25.5%, 30.2%]
6305/10330
59.4%
[57.1%, 61.7%]
Antivirals of Interest
744/5814
7.7%
[5.7%, 10.3%]
1458/5306
27.1%
[23.7%, 30.7%]
2856/4811
57.6%
[54.3%, 60.9%]
Other Pharmaceutical Interventions
70/445
15.4%
[8.0%, 27.5%]
49/252
20.2%
[10.8%, 34.6%]
256/393
64.1%
[56.9%, 70.7%]
Secondary Interventions
Control/Standard of Care
1113/5930
12.6%
[9.6%, 16.4%]
1641/5659
30.3%
[27.0%, 33.8%]
3193/5126
61.7%
[57.9%, 65.4%]